Héctor Dueñas

1.1k total citations
36 papers, 825 citations indexed

About

Héctor Dueñas is a scholar working on Pharmacology, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Héctor Dueñas has authored 36 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 19 papers in Psychiatry and Mental health and 10 papers in Physiology. Recurrent topics in Héctor Dueñas's work include Treatment of Major Depression (19 papers), Pain Mechanisms and Treatments (10 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (8 papers). Héctor Dueñas is often cited by papers focused on Treatment of Major Depression (19 papers), Pain Mechanisms and Treatments (10 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (8 papers). Héctor Dueñas collaborates with scholars based in United States, Spain and China. Héctor Dueñas's co-authors include Levent Alev, Diego Novick, Alan Brnabic, William Montgomery, Luiz Alberto B. Hetem, Carlos López‐Jaramillo, Rodrigo Muñoz, Jerson Laks, Kristin Kahle‐Wrobleski and Amir Goren and has published in prestigious journals such as Psychological Medicine, Journal of Affective Disorders and The Journal of Clinical Psychiatry.

In The Last Decade

Héctor Dueñas

36 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Héctor Dueñas United States	16	377	345	202	170	139	36	825
Michael D. Stensland United States	16	196 0.5×	786 2.3×	241 1.2×	114 0.7×	79 0.6×	30	1.1k
John G. Watkin United States	24	874 2.3×	602 1.7×	216 1.1×	495 2.9×	200 1.4×	36	1.5k
James M. Ellison United States	20	210 0.6×	464 1.3×	152 0.8×	78 0.5×	141 1.0×	77	1.1k
Vineeth John United States	4	131 0.3×	631 1.8×	329 1.6×	77 0.5×	157 1.1×	5	1.2k
Tamás Treuer United States	21	137 0.4×	1.1k 3.1×	128 0.6×	62 0.4×	140 1.0×	88	1.4k
Michael S. Shutty United States	18	381 1.0×	420 1.2×	180 0.9×	46 0.3×	199 1.4×	42	1.1k
Stephanie C. Koke United States	12	289 0.8×	183 0.5×	76 0.4×	133 0.8×	45 0.3×	19	795
Marcy Wohl United States	14	155 0.4×	476 1.4×	99 0.5×	141 0.8×	338 2.4×	23	944
Boaz Bloch Israel	16	125 0.3×	131 0.4×	109 0.5×	82 0.5×	131 0.9×	26	797
Arianna Goracci Italy	18	106 0.3×	338 1.0×	111 0.5×	117 0.7×	114 0.8×	56	1.0k

Countries citing papers authored by Héctor Dueñas

Since Specialization

Citations

This map shows the geographic impact of Héctor Dueñas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Héctor Dueñas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Héctor Dueñas more than expected).

Fields of papers citing papers by Héctor Dueñas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Héctor Dueñas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Héctor Dueñas. The network helps show where Héctor Dueñas may publish in the future.

Co-authorship network of co-authors of Héctor Dueñas

This figure shows the co-authorship network connecting the top 25 collaborators of Héctor Dueñas. A scholar is included among the top collaborators of Héctor Dueñas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Héctor Dueñas. Héctor Dueñas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Guochun, Xiang-Pei Li, Zhijun Li, et al.. (2019). Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data. BMC Musculoskeletal Disorders. 20(1). 174–174. 9 indexed citations

Li, Yue, et al.. (2019). <p>Clinical meaningfulness of duloxetine's effect in Chinese patients with chronic pain due to osteoarthritis: post hoc analyses of a phase 3 randomized trial</p>. Open Access Rheumatology Research and Reviews. Volume 11. 67–76. 1 indexed citations

Novick, Diego, et al.. (2017). Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study. Patient Preference and Adherence. Volume 11. 1859–1868. 24 indexed citations

Park, Hyun Jun, et al.. (2017). Safety and Effectiveness of Once-Daily Tadalafil (5 mg) Therapy in Korean Men with Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms in a Real-World Clinical Setting: Results from a Post-Marketing Surveillance Study. The World Journal of Men s Health. 36(2). 161–161. 7 indexed citations

Hong, Jihyung, Diego Novick, María Victoria Moneta, et al.. (2017). Functional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East. Clinical Practice and Epidemiology in Mental Health. 13(1). 145–155. 2 indexed citations

Novick, Diego, William Montgomery, Josep María Haro, et al.. (2016). Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia. Neuropsychiatric Disease and Treatment. 12. 383–383. 3 indexed citations

Dodd, Seetal, Alexander Schacht, Katarina Kelin, et al.. (2015). Nocebo Effects in the Treatment of Major Depression. The Journal of Clinical Psychiatry. 76(6). 702–711. 21 indexed citations

Hong, Jihyung, et al.. (2015). Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study. Neuropsychiatric Disease and Treatment. 11. 197–197. 15 indexed citations

Hong, Jihyung, Diego Novick, William Montgomery, et al.. (2015). Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?. Clinical Practice and Epidemiology in Mental Health. 11(1). 130–139. 5 indexed citations

10.

Hong, Jihyung, Diego Novick, William Montgomery, et al.. (2015). Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting. Patient Preference and Adherence. 9. 1481–1481. 2 indexed citations

11.

Schacht, Alexander, et al.. (2014). Impact of Pretreatment With Antidepressants on the Efficacy of Duloxetine in Terms of Mood Symptoms and Functioning. The Primary Care Companion For CNS Disorders. 16(5). 2 indexed citations

12.

Treuer, Tamás, Chia-Yih Liu, Gerardo A. Salazar, et al.. (2013). Use of antidepressants in the treatment of depression in Asia: Guidelines, clinical evidence, and experience revisited. Asia-Pacific Psychiatry. 5(4). 219–230. 10 indexed citations

13.

Treuer, Tamás, Susan Shur‐Fen Gau, Luis Méndez, et al.. (2013). A Systematic Review of Combination Therapy with Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder, Including Patient Characteristics, Treatment Strategies, Effectiveness, and Tolerability. Journal of Child and Adolescent Psychopharmacology. 23(3). 179–193. 39 indexed citations

14.

Dueñas, Héctor, Arier Lee, Alan Brnabic, et al.. (2011). Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study. International Journal of Psychiatry in Clinical Practice. 15(2). 80–90. 25 indexed citations

15.

Dueñas, Héctor, et al.. (2011). Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico. Journal of Medical Economics. 15(2). 233–244. 9 indexed citations

16.

Gaynor, Paula J., et al.. (2011). Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies. International Journal of Clinical Practice. 65(3). 341–349. 13 indexed citations

17.

Dueñas, Héctor, Alan Brnabic, Arier Lee, et al.. (2011). Treatment-emergent sexual dysfunction with SSRIs and duloxetine: Effectiveness and functional outcomes over a 6-month observational period. International Journal of Psychiatry in Clinical Practice. 15(4). 242–254. 27 indexed citations

18.

Dueñas, Héctor, Carmen Lara, Richard Walton, et al.. (2011). The integral inventory for depression, a new, self-rated clinimetric instrument for the emotional and painful dimensions in major depressive disorder. International Journal of Psychiatry in Clinical Practice. 15(3). 171–179. 3 indexed citations

19.

Nicolini, Humberto, David Bakish, Héctor Dueñas, et al.. (2008). Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial. Psychological Medicine. 39(2). 267–276. 58 indexed citations

20.

Dueñas, Héctor, et al.. (2006). Effectiveness of antidepressants in the treatment of major depressive disorder in Latin America. International Journal of Psychiatry in Clinical Practice. 11(2). 129–139. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact